Immigration policy isn't really what we at HHS do.
President Trump has exposed the dirty secret of drug pricing: There is a shadowy third player in the transaction between patients and their pharmacists: middlemen who have taken a big kickback from the drug manufacturer, which may or may not be reflected in patients' out-of-pocket costs.
Patients who face long odds and terminal illnesses do not always have access to the latest drugs in clinical trials. They don't want to give up, but they don't have years to wait for new drugs to receive FDA approval.
We at HHS are working with President Trump on a comprehensive plan to bring down the high price of prescription drugs.
What one has created by regulation, one could address by regulation.
The mission of HHS is to enhance the health and well-being of all Americans, and this includes the unborn.
The Medicare program is a great promise we've made to our seniors. But if you start expanding that out to everybody else, you're going to undermine the employer insurance market.
